A Multicenter Assessment of ALD403 in Chronic Migraine
Clinical trial NCT02275117 · COMPLETED
Trial details
- NCT number
- NCT02275117
- Sponsor
- Alder Biopharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-03-01
- Enrollment
- 665
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.